|
TIGECYCLINE | ||
PRODUCT IDENTIFICATION |
||
CAS NO. | 220620-09-7 |
|
EINECS NO. | ||
FORMULA | C29H39N5O8 | |
MOL WT. | 585.65 | |
H.S. CODE |
2941.30.0000 | |
SYNONYMS | Tygacil; Achromycin V, Tetracyn, Tetrex; | |
(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)- 1,4,4a,5,5a,6,11, 12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11, 12a-octahydro- 3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; | ||
SMILES |
CC(C)(C)NCC(=O)Nc1cc(c2c(c1O)C(=O)C3=C([C@]4([C@@H] (C[C@ @H] 3C2)[C@@H](C(=C(C4=O)C(=O)N)O)N(C) C)O)O)N(C)C | |
CLASSIFICATION |
Tetracycline, Antibacterial | |
EXTRA NOTES |
||
PHYSICAL AND CHEMICAL PROPERTIES |
||
PHYSICAL STATE | Orange crystalline powder | |
MELTING POINT | ||
BOILING POINT |
|
|
SPECIFIC GRAVITY | ||
SOLUBILITY IN WATER | ||
pH | 7.0 ~ 8.5 | |
VAPOR DENSITY |
|
|
AUTOIGNITION |
||
NFPA RATINGS |
||
REFRACTIVE INDEX |
|
|
FLASH POINT | ||
STABILITY |
Stable under ordinary conditions. |
|
GENERAL DESCRIPTION AND APPLICATIONS |
||
Wikipedia Linking: http://en.wikipedia.org/wiki/Tigecycline Tigecycline is an antibiotic that is used intravenously for the treatment of infections of the skin and abdominal organs caused by bacteria that are susceptible to it. Tigecycline is similar to tetracycline antibiotics and has activity against a large number of bacteria. Tigecycline binds to bacterial ribosomes, organelles inside the bacteria that produce the cell's proteins. The binding prevents the bacterial ribosomes from producing important proteins that are needed for growth and multiplication of the bacteria. Tigecycline prevents a bacterium from multiplying, but it does not kill the bacterium. Tigecycline was approved by the FDA in June, 2005. (http://www.medicinenet.com/)Tigecycline, a derivative of the tetracycline (Some Trade Names ACHROMYCIN V, TETRACYN, TETREX) minocycline (Some Trade Names, is the first available glycylcycline. Tigecycline inhibits protein synthesis by binding to the 30S ribosomal subunit. It is bacteriostatic. Tigecycline is given IV. Tigecycline has a large volume of distribution (> 12 L/kg), penetrating well into bone, lung, liver, and kidney tissues. A half-life of 36 h should provide for once/day dosing. Most of the drug is excreted in bile and feces. Tigecycline is effective against many resistant bacteria, including those with resistance to tetracyclines. Tigecycline is active against
Tigecycline is the first drug in the glycylcycline class of antibiotics. Although it is structurally related to minocycline, alterations to the molecule resulted in its expanded spectrum of activity and decreased susceptibility to the development of resistance when compared with other tetracycline antibiotics. Tigecycline has a broad spectrum of activity, including activity against drug-resistant gram-positive organisms. (http://www.baylorhealth.edu/) Tetracycline antibiotics include;
|
||
SALES SPECIFICATION | ||
APPEARANCE |
Orange crystalline powder | |
CONTENT |
99.0% min |
|
WATER |
3.0% max |
|
RELATED SUBSTANCES |
Isomer
Impurity: 1.5% max |
|
TRANSPORTATION | ||
PACKING |
|
|
HAZARD CLASS | ||
UN NO. | ||
OTHER INFORMATION | ||
Hazard Symbols: XN, Risk Phrases: 63, Safety Phrases: 36/37-45 | ||
PRICE INFORMATION | ||
|